- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05969756
Early Treatments for Preventing Occlusal Caries Lesions
August 13, 2023 updated by: Le Van Nhat Thang, Hue University of Medicine and Pharmacy
Clinical Effectiveness of Early Treatments for Preventing Occlusal Caries Lesions in Erupting Permanent Molars
Sealants effectively arrest non-cavitated caries lesions on the fully erupted occlusal surface of permanent teeth.
However, the clinical effectiveness of sealants is uncertain in preventing occlusal caries lesions in partially erupted permanent molars.
This study aims to evaluate the progression of caries, the degree of retention, survival rate, and quality of the remnant after applying conventional total-etch resinous sealant and self-etch sealant in erupting molars.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Van Nhat Thang Le, DDS, PhD
- Phone Number: +84931199077
- Email: lvnthang@hueuni.edu.vn
Study Locations
-
-
Thua Thien Hue
-
Hue, Thua Thien Hue, Vietnam, 49120
- Recruiting
- Hue University of Medicine and Pharmacy
-
Contact:
- Thanh Thao Nguyen, MD, PhD
- Email: stir@huemed-univ.edu.vn
-
Phu Vang, Thua Thien Hue, Vietnam, 49900
- Recruiting
- Phu Vang Hospital
-
Contact:
- Van Lich Tran, DDS
- Email: tranvanlich85@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
For children:
- Children presenting with good general health and cooperative behavior.
- Children having early caries lesions in a permanent molar (first or second).
- Parents signed informed consent.
For permanent molars:
- Early caries lesions on the occlusal surface corresponding to International Caries Detection and Assessment System (ICDAS) scores 1 and 2. [Ismail AI, Sohn W, Tellez M, Amaya A, Sen A, Hasson H, Pitts NB. The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries. Community Dent Oral Epidemiol. 2007 Jun;35(3):170-8].
- Erupting molars: eruption stages 2 (fully erupted occlusal surface with less than half of the crown exposed) and 3 (fully erupted occlusal surface with more than half of the crown exposed). [Carvalho JC, Ekstrand KR, Thylstrup A. Dental plaque and caries on occlusal surfaces of first permanent molars in relation to stage of eruption. J Dent Res. 1989 May;68(5):773-9].
Exclusion Criteria:
For children:
- Any allergy reported by the parents.
- Children unable to return for recall visits.
For permanent molars:
- Teeth with occlusal surfaces completely covered by the gingival tissue.
- Teeth with hypoplastic defects, restorations, or sealants.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fluoride varnish group
5% sodium fluoride varnish, 3M, USA
|
Thirty-eight permanent molars will receive 5% sodium fluoride varnish application every three months
Other Names:
|
Experimental: Conventional etch and rinse sealant group
Resin-based composite sealant, 3M, USA
|
Thirty-eight permanent molars will receive conventional etch and rinse sealant
Other Names:
|
Active Comparator: Self-etch sealant group
Self-etch primed sealant, Shofu, Japan
|
Thirty-eight permanent molars will receive self-etch sealant
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Development of new caries lesion
Time Frame: 3 months
|
ICDAS was considered "0'' for fully sealed teeth.
A score of ICDAS≥1 was considered as new caries lesion
|
3 months
|
Development of new caries lesion
Time Frame: 6 months
|
ICDAS was considered "0'' for fully sealed teeth.
A score of ICDAS≥1 was considered as new caries lesion
|
6 months
|
Development of new caries lesion
Time Frame: 9 months
|
ICDAS was considered "0'' for fully sealed teeth.
A score of ICDAS≥1 was considered as new caries lesion
|
9 months
|
Development of new caries lesion
Time Frame: 12 months
|
ICDAS was considered "0'' for fully sealed teeth.
A score of ICDAS≥1 was considered as new caries lesion
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sealants retention
Time Frame: 3 months
|
Sealant retention was assessed as follows: total retention of sealant on the occlusal surface or the partial or complete absence of the sealant on the occlusal surface.
|
3 months
|
Sealants retention
Time Frame: 6 months
|
Sealant retention was assessed as follows: total retention of sealant on the occlusal surface or the partial or complete absence of the sealant on the occlusal surface.
|
6 months
|
Sealants retention
Time Frame: 9 months
|
Sealant retention was assessed as follows: total retention of sealant on the occlusal surface or the partial or complete absence of the sealant on the occlusal surface.
|
9 months
|
Sealants retention
Time Frame: 12 months
|
Sealant retention was assessed as follows: total retention of sealant on the occlusal surface or the partial or complete absence of the sealant on the occlusal surface.
|
12 months
|
Quality of sealants
Time Frame: 3 months
|
Quality of the remnant United States Public Health Service criteria (USPHS): anatomical shape, marginal adaptation, surface texture, and marginal discoloration.
|
3 months
|
Quality of sealants
Time Frame: 6 months
|
Quality of the remnant United States Public Health Service criteria (USPHS): anatomical shape, marginal adaptation, surface texture, and marginal discoloration.
|
6 months
|
Quality of sealants
Time Frame: 9 months
|
Quality of the remnant United States Public Health Service criteria (USPHS): anatomical shape, marginal adaptation, surface texture, and marginal discoloration.
|
9 months
|
Quality of sealants
Time Frame: 12 months
|
Quality of the remnant United States Public Health Service criteria (USPHS): anatomical shape, marginal adaptation, surface texture, and marginal discoloration.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Van Nhat Thang Le, DDS, PhD, Hue University of Medicine and Pharmacy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 31, 2023
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
July 23, 2023
First Submitted That Met QC Criteria
July 23, 2023
First Posted (Actual)
August 1, 2023
Study Record Updates
Last Update Posted (Actual)
August 15, 2023
Last Update Submitted That Met QC Criteria
August 13, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H2023/012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Will plan to share information when finishing study
IPD Sharing Time Frame
Plan to complete study in 1 year and will share the data after get publication
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Occlusal Caries
-
Cairo UniversityUnknown
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityActive, not recruiting
-
Cairo UniversityUnknown
-
Cairo UniversityUnknown
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknownCaries in Occlusal Surface of Primary and Permanent DetitionBrazil
-
Cairo UniversityNot yet recruiting
-
Universitat Internacional de CatalunyaCompleted
-
Mansoura UniversityCompleted
-
CES UniversityUniversidad de AntioquiaUnknown
Clinical Trials on Fluoride varnish
-
Indira Gandhi Institute of Dental ScienceCompletedEvaluation of Remineralizing Efficacy of Combination Varnishes on White Spot Lesions in ECC ChildrenChild | Early Childhood Caries
-
The University of Hong KongUnknownWhite Spot Lesion | Caries,Dental | Demineralization, ToothHong Kong
-
Khon Kaen UniversityCompletedQuality of Life | Dental Caries in Children | Satisfaction | Oral Health | Cost EffectivenessThailand
-
Nourhan M.AlyAlexandria UniversityCompleted
-
Advantage Dental Services, LLCCompleted
-
Merve Erkmen AlmazCompletedEarly Childhood Caries
-
The University of Hong KongRecruitingRoot Caries | Dental Caries of Root SurfaceHong Kong
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityUnknownDental Caries in ChildrenEgypt
-
Cairo UniversityUnknownDental Caries in ChildrenEgypt